In silico and in vivo models for Qatari-specific classical homocystinuria as basis for development of novel therapies
Hesham M. Ismail(Qatar University), Gheyath K. Nasrallah(Qatar University), Henk J. Blom(Erasmus MC), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Johannes Häberle(University Children's Hospital Zurich), Beat Thöny(Swiss Integrative Center for Human Health), Hatem Zayed(Qatar University), Valeria Di Giacomo(Barcelona Biomedical Research Park), Nader Al‐Dewik(St George's, University of London), Warren D. Kruger(Fox Chase Cancer Center), Nura A. Mohamed(Qatar University), Sapna Gupta(Fox Chase Cancer Center), Navaneethakrishnan Krishnamoorthy(Sidra Medical and Research Center)
Cited by 21
Related Papers
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Suggested guidelines for the diagnosis and management of urea cycle disorders
|Orphanet Journal of Rare Diseases|2012|627